(Q40475019)
Statements
Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein (English)
Michael F Good
Colleen Olive
Hsien Kuo Sun
Mei-Fong Ho
Joanne Dyer